
Loading, please wait...

Loading, please wait...

The mammalian circadian clock functions as a sophisticated molecular timer. At its core, a negative feedback loop involves the transcription factors CLOCK and BMAL1. These factors drive the expression of Period (PER) and Cryptochrome (CRY) proteins. However, the precise timing of this loop depends on the circadian kinase CK1δ. Recent evidence suggests that the nuclear availability of CK1δ is a major factor in determining the length of the circadian period. Researchers have found that the cell strictly limits the amount of this kinase in the nucleus through rapid degradation and active export.
Moreover, the circadian kinase CK1δ regulates how PER and CRY proteins interact within the cell. Specifically, phosphorylation mediated by this kinase can disrupt the interaction between PER2 and CRY1. This disruption leads to the accumulation of PER2 in the cytoplasm during the later stages of the circadian cycle. Consequently, CRY1 is released and accumulates in the nucleus. This transition is essential for sustaining the repression of CLOCK:BMAL1 on the DNA. Therefore, CK1δ acts as a molecular switch that supports the transition from the early to the late repressive phase of the clock.
Understanding these molecular pathways is vital for clinical practice in India. Circadian disruptions often lead to sleep disorders, metabolic syndromes, and psychiatric conditions. For instance, mutations in the genes regulating PER2 stability can result in Familial Advanced Sleep Phase Syndrome. Additionally, the clearing of nuclear PER2 and the release of CRY1 ensure that the clock remains synchronized with environmental cues. Future therapies targeting CK1δ could potentially help manage jet lag, shift work disorders, and even type 2 diabetes. Furthermore, clinicians can use this knowledge to better understand the chronobiology of their patients.
CK1δ regulates the stability and localization of PER proteins, effectively timing the transition between different phases of transcriptional repression in the biological clock.
The cell limits nuclear CK1δ through rapid degradation and active export of the kinase when it is not part of a protein complex, ensuring the clock runs at the correct speed.
Dissociation allows CRY1 to enter the nucleus and sustain the inhibition of gene transcription, which is necessary for the proper progression of the 24-hour cycle.
Disclaimer: This content is for informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Refer to the latest local and national guidelines for clinical practice.
References
Serrano FE et al. Nuclear CK1δ as a critical determinant of PER:CRY complex dynamics and circadian period. Elife. 2026 Jun 15. doi: undefined. PMID: 42290481.
Toh KL et al. An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome. Science. 2001;291(5506):1040-1043.
Narasimamurthy R, Virshup DM. The phosphorylation switch that regulates the mammalian circadian clock. Bioessays. 2021;43(1):e2000211.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A new study reveals that nuclear CK1δ is a critical determinant of the circadian period. By modulating the dynamics of the PER:CRY complex, this kinase manages the transition between repressive phases in the biological clock, providing a deeper understanding of sleep and metabolic rhythms.
4 months ago

Explore vital recurrent stroke predictors in lacunar stroke patients managed with intensive blood pressure lowering. This analysis examines trial findings from SPS3 to uncover residual vascular risks, metabolic factors, and targeted secondary prevention strategies for high-risk neurological patients.
Today

Odisha has established India's first state-level clinical protocol specifically tailored for pregnant women with sickle cell disease. Developed with NHM and UNICEF, the framework provides structured antenatal screening, crisis mitigation, standardized referral pathways, and specialized interdisciplinary care.
Today

India is advancing preventive healthcare by integrating genomics, artificial intelligence, and quantum technologies. With the SANGAM programme sequencing one million Indian genomes, clinicians can unlock personalized therapies, detect cardiometabolic risks early, and curb the burden of diabetes and heart disease.
Today

A randomized controlled trial demonstrates that an eight-week dual-task training intervention significantly improves static and dynamic postural control over standard balance exercises in individuals with chronic ankle instability, addressing critical neurocognitive deficits during athletic and daily activities.
Today

A retrospective cohort study of 7,716 ICU patients from the MIMIC-IV database demonstrates that Gradient Boosting Decision Trees significantly outperform traditional SOFA scores in predicting in-hospital mortality among patients with sepsis and diabetes, with SHAP analysis providing clinical interpretability.
Today